The Cancer Letter

Inside information on cancer research and drug development

In Brief

Mount Sinai and Valley Health System to form partnership

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

MOUNT SINAI HEALTH SYSTEM and Valley Health System plan to form a partnership that will enable Valley to access Mount Sinai’s roster of clinical trials, as well as develop new programs and services.

In December 2015, Valley and Mount Sinai announced plans to collaborate on clinical programs, research and educational offerings. Mount Sinai and Valley plan to work together at Valley’s Blumenthal Cancer Center in Paramus and the main campus in Ridgewood by establishing a linked clinical information system.

According to Robert Korst, medical director of Valley’s Blumenthal Cancer Center, among the first Mount Sinai clinical trials that Valley patients will have access to include new treatments and treatment protocols for cutaneous malignancies, including melanoma and other skin cancers; genitourinary malignancies, including prostate and kidney cancers; and hematologic cancers and serious blood disorders, including leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes. Some treatment protocols will include bone marrow transplantation and immunotherapeutic vaccines.

Table of Contents

YOU MAY BE INTERESTED IN

White House

Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
By Paul Goldberg
Capitol Hill

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
By Claire Marie Porter
Guest Editorial

Cancer research fuels life-saving work

Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 
By Ze’ev Ronai
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account